IL1B and metabolic disease: Next, SUA activates the NLRP3, a multi-protein complex that can activate the production of pro-inflammatory cytokines, such as IL-1β (49, 50), a potent inflammatory mediator that induces the release of other inflammatory factors, creating an inflammatory cascade response (50), which is closely associated with metabolic diseases (51).